-
-
-
-
-
-
-
PolyPid Ltd. (PYPD) Misses Q4 EPS by 8c
-
-
-
-
-
-
-
PolyPid unveils 60-day GLP-1 delivery platform for diabetes treatment
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on PolyPid Ltd. (PYPD)
-
-
-
-
-
-
-
PolyPid Ltd. (PYPD) Announces Publication in International Journal of Surgery Highlighting Results of Phase 3 SHIELD I Trial of D-PLEX₁₀₀ in Prevention of Surgical Site Infections in Abdominal C
-
-
-
-
456,379 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

